# Compound GLP > Compounded GLP-1s: 503A and 503B pharmacies, the FDA shortage list and its end, salt forms, dosing errors reported to the FDA, lawsuits, and how to judge a compounder's quality. Compound GLP is written by a small editorial team that reads FDA inspection reports, warning letters, court filings and the testing studies on compounded GLP-1 drugs. We cite everything. We sell no drugs, recommend no pharmacy and take no money from compounders or drug makers. ## Articles - [Compounded Semaglutide: What You Are Actually Getting](https://compoundglp.com/compounded-semaglutide/): Compounded semaglutide explained: where the ingredient comes from, what testing it gets, why the multiple-dose vial caused dosing errors, and what followed the shortage. - [Compounded Tirzepatide and the Shortage That Ended](https://compoundglp.com/compounded-tirzepatide/): Compounded tirzepatide lost its legal footing when the FDA ended the shortage in 2024. Here is what the deadlines, the Fifth Circuit ruling, and the lawsuits mean. - [What Is a Compounding Pharmacy, and Why Did It Become a Weight-Loss Business?](https://compoundglp.com/what-is-a-compounding-pharmacy/): What is a compounding pharmacy? A plain look at how patient-specific mixing became a mass GLP-1 supply chain, and what the FDA is now doing about it. - [503A vs 503B: The Two Kinds of Compounder the Law Allows](https://compoundglp.com/503a-vs-503b/): A 503a pharmacy compounds only against a patient-specific prescription under state board oversight. See how that differs from a 503B outsourcing facility and why. - [Inside a 503B Outsourcing Facility](https://compoundglp.com/503b-outsourcing-facility/): A 503B outsourcing facility trades the light pharmacy rulebook for factory rules and FDA inspections. Learn what it may make and why GLP-1 batches ended. - [The Semaglutide Shortage: How a Drug Gets on the List and Off It](https://compoundglp.com/semaglutide-shortage/): The semaglutide shortage ended legally on February 21, 2025, by FDA order. Learn why a list, not pharmacy shelves, decided who could compound, and what followed. - [What Happened When the GLP-1 Shortages Ended](https://compoundglp.com/after-the-shortage-ended/): Is compounded semaglutide still legal? Only narrowly: 503A pharmacies can personalize for one patient, while mass copying ended with the shortage in February 2025. - [Semaglutide Sodium and Acetate: Why the Salt Form Matters](https://compoundglp.com/semaglutide-sodium/): Semaglutide sodium is not the semaglutide in Ozempic or Wegovy. See why FDA says no lawful compounding route exists and what the missing data means. - [Is Compounded Semaglutide Safe? What the Evidence Shows](https://compoundglp.com/is-compounded-semaglutide-safe/): Is compounded semaglutide safe? No trial has tested it. The safety record is mostly reports of vial dosing errors, plus thinner evidence on potency and ingredients. - [The Dosing Errors FDA Keeps Seeing With Compounded GLP-1s](https://compoundglp.com/compounded-glp1-dosing-errors/): Compounded semaglutide dosing errors, per the FDA's July 2024 alert: patients drew up 5 to 20 times the intended dose from multiple-dose vials, and why. - [Why Compounded Tirzepatide Costs What It Costs](https://compoundglp.com/compounded-tirzepatide-cost/): Compounded tirzepatide cost has no published figure. Here is what the sources show on pricing: semaglutide at $150 to $400, brand drugs falling, and a hidden markup. - [The Compounded GLP-1 Lawsuits: Novo, Lilly and the Outsourcing Facilities](https://compoundglp.com/compounded-glp1-lawsuits/): Compounded semaglutide lawsuit explained: the OFA challenge to the FDA shortage ruling, Novo Nordisk's 132 complaints and 44 injunctions, and a patent suit. - [How to Judge a Compounding Pharmacy's Quality](https://compoundglp.com/judge-a-compounding-pharmacy/): No official list names the best compounding pharmacy. Learn the four checkable signals: PCAB accreditation, USP 797, testing and API sourcing, and how to read them. - [What Independent Labs Found When They Tested Compounded Semaglutide](https://compoundglp.com/compounded-semaglutide-potency-testing/): Compounded semaglutide testing is mostly after-the-fact: FDA letters cite 79.9% potency, tirzepatide labs show wide spreads, and dosing errors loom larger. - [How Telehealth Weight-Loss Brands Built a Business on Compounders](https://compoundglp.com/telehealth-and-compounding/): A compounded GLP-1 sold online often carries the telehealth brand's name, not the pharmacy's. Here is how the shortage rules, ad law and FDA letters fit together. - [Compounded vs Brand Semaglutide: The Differences That Matter](https://compoundglp.com/compounded-vs-brand-semaglutide/): Compounded ozempic is not Ozempic. A side-by-side of source, testing, vials and the 'essentially a copy' rule, plus where the law stands after the shortage. - [USP 797: The Rulebook for Sterile Compounding](https://compoundglp.com/usp-797-sterile-compounding/): USP 797 sets sterile compounding rules, and its beyond-use date quietly shapes compounded GLP-1 supply, from one syringe to the end of a federal shortage. - [What FDA Inspectors Write Down at Compounding Pharmacies](https://compoundglp.com/fda-483-compounding-inspections/): FDA 483 compounding explained: the top observation categories at outsourcing facilities, what a Form 483 is, and why GLP-1 warning letters keep turning to advertising. - [How to Check a Compounding Pharmacy Near You Is Legitimate](https://compoundglp.com/verify-a-compounding-pharmacy/): Searching for a compounding pharmacy near me is the quick check. Here is what a state license, 503A or 503B status, and FDA warning letters each tell you. - [Compounded GLP-1s With Added B12 or Glycine: Medicine or Marketing?](https://compoundglp.com/compounded-glp1-additives/): Semaglutide with B12 is compounded semaglutide plus cyanocobalamin, not an FDA-approved product. See what a 2025 survey and the safety data do and do not show. ## Tools - [The Compounding Pharmacy Quality Scorecard](https://compoundglp.com/scorecard/): Twenty questions that separate a careful compounder from a risky one, drawn from FDA inspection findings, USP standards and independent potency testing, with what a good answer sounds like. ## Listen - [Compounded Weight Loss Drugs Under the Microscope](https://compoundglp.com/#listen): 32 minutes. A narrated research briefing from the Compound GLP editors, with every source checked. ## Optional - [About](https://compoundglp.com/about/) - [Sitemap](https://compoundglp.com/sitemap.xml)